Escin clinical trials
How each study uses Escin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Escin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Escin
- 3
Studies by the year they started
3 studies that test it; most in 2020 (1)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
University of Science and Technology, Yemen (1) · Oman Medical Speciality Board (1) · University of Catanzaro (1)
Often tested with
Tested in the same studies.
Serratiopeptidase (1)
Studies
Open first, then newest update. How each study uses Escin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Aescin-Based Herbal Extract (Reparil) for Postoperative Sequelae After Mandibular Third Molar SurgeryRecruitingNot applicableOman Medical Speciality BoardNCT07244029Written as Escin
- A Comparison of Recovery After Impacted Wisdom Tooth RemovalCompletedPhase 3University of Science and Technology, YemenNCT07304882Written as Escin
- Escin in Patients With Covid-19 InfectionStatus unknownPhase 2/3University of CatanzaroNCT04322344Written as Escin
Codes
What other systems call Escin · ClinicalTrials.gg INT007438
- MeSH (NLM) D004928EscinConfirmed ClinicalTrials.gov, NLM
- RxNorm 4065One source FDA
- Wikidata Q381866escin IaOne source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D004928 | Escin | Confirmed ClinicalTrials.gov, NLM |
| RxNorm | 4065 | — | One source FDA |
| Wikidata | Q381866 | escin Ia | One source Wikidata |
Also registered as .beta.-escin (UNII QYK0D6H79O · RxNorm 1476).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.